HealthQuill Opioids
Amneal Pharmaceuticals Inc., will pay $270 million to settle claims arising out of its role in fuelling a nationwide opioid epidemic, according to a company statement.
Drugs Health Pharma

Amneal Pharmaceuticals to pay $270m to settle opioid claims in US

HQ Team May 5, 2024: Amneal Pharmaceuticals Inc., will pay $270 million to settle claims arising out of its role in fuelling a.

Read More
Higher temperatures have led to a rise in hospital visits for the treatment of alcohol and substance-related disorders in the US.
Climate Health Pharma

US hospitals see alcohol, opioid cases rise due to high temperatures

HQ Team September 27, 2023: Higher temperatures led to a rise in hospital visits for the treatment of alcohol and substance-related disorders in.

Read More
American-Irish pharmaceutical company, Mallinckrodt Pharmaceuticals, and its “certain” subsidiaries have filed for a second bankruptcy in the US after reaching a pact with their creditors to cut the opioid-related settlement payments by about $1 billion.
Drugs Health Pharma

Opioid hit Mallinckrodt files for 2nd bankruptcy, plaintiffs may lose

HQ Team August 28, 2023: American-Irish pharmaceutical company, Mallinckrodt Pharmaceuticals, and its “certain” subsidiaries have filed for a second bankruptcy in the US after.

Read More
Emergent BioSolutions, will sack 400 employees across its various facilities to focus on core business products meant to treat opioid overuse, anthrax, Ebola and smallpox.
Drugs Health Pharma

Emergent BioSolutions to cut 400 jobs to focus on core products

HQ Team August 9, 2023: Emergent BioSolutions, will sack 400 employees across its various facilities to focus on core business products meant to.

Read More
Harm Reduction Therapeutics’s RiVive has become the second opioid overdose reversal drug the FDA allows without a prescription in the US.
Drugs Health Pharma

USFDA gives nod for second opioid overdose reversal drug ReVive

HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid.

Read More
The toxicity rate related to benzodiazepine, a drug used to treat insomnia and anxiety and doubles up as an opioid, rose sharply in young adults and youth in Canada’s Ontario province that borders the US.
Drugs Health Pharma

Rising toxicity in Benzos snorted by Ontario’s young adults raises alarm in Canada

HQ Team June 20, 2023: The toxicity rate related to benzodiazepine, a drug used to treat insomnia and anxiety and doubles up as.

Read More
New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose, the FDA stated.
Drugs Health Medical Pharma

USFDA updates safety warnings for opioid treatment drugs 

HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.

Read More
US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.
Drugs Health Pharma

FDA clears Emergent’s nasal spray for opioid overuse to sell at pharmacies

US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.

Read More
X